Team Finds Potential Drug Targets in Deadly Pediatric Brain Tumors

  • SHARE
  • EmailFacebookTwitter
    Share on Facebook
    Cancel
    Share on MySpace
    Cancel
    Share on Twitter
    A short URL will be added to the end of your Tweet.

    Cancel
    Share on LinkedIn
    Cancel
Printer Friendly

April 8, 2014

Click here to read the full article about new research in pediatric high-grade astrocytoma treatment.

Related News

Researchers Identify Key Pathway in Aggressive Pediatric Brain Cancer

February 25, 2015

Researchers have uncovered a genetic pathway that plays a major role in cancer cell growth. Better yet, they may even have a drug that fights it.

Celldex's Rindopepimut (Rintega(R)) Receives FDA Breakthrough Therapy Designation for the Treatment of Adult Patients with EGFRvIII-positive Glioblastoma

February 23, 2015

Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced that the U.S. Food and Drug Administration (FDA) has granted rindopepimut (Rintega®) Breakthrough Therapy Designation for the treatment of adult patients with EGFRvIII-positive glioblastoma (GBM).

Researchers Identify Promising New Target for Developing Better Therapies for Neuroblastoma Kids

January 22, 2015

Learn more about research for pediatric neuroblastoma.